CYTOVIA Inc., IMMUNE Pharma’s Oncology Subsidiary, Announces the Publication of New Results in the British Journal of Haematology and Filing of a World-wide Patent Protecting the Use of Ceplene® in ...

HOUSTON ― According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) ...

Arsenic and old ideas once used to treat a deadly cancer are being overhauled by enormous strides in new treatments, turning ...

CML affects between 1.6 and 2 individuals per 100 000 worldwide each year but represents nearly 15% of all leukaemia cases. Eastern Cape-based haematology NGO, the Igazi Foundation, has founded the ...

There are more chronic myelogenous leukaemia (CML) sufferers in Hong Kong than ever. But that's a good thing because it means patients are living longer, according to experts. Once an almost ...

Lucknow: Chronic Myeloid Leukemia (CML) — which forms a major share of adult blood cancer cases in Uttar Pradesh — can now be effectively managed with just one targeted pill a day, allowing patients ...

Kolkata: On World Chronic Myeloid Leukaemia (CML) Day, Kolkata Haematology Education & Research Initiative (KHERI) has chalked out a plan to start a support group for patients suffering from the ...

Bangalore : The increasing role played by genetics in diseases particularly haematological diseases was highlighted at the 56th Annual meeting of the Indian Society of Haematology and Blood ...

Historically, treatment for blood cancers, relied heavily on chemotherapy. However, this “carpet bombing” approach, apart from destroying cancer cells also affects healthy, rapidly-dividing cells.